Advertisement

Topics

Search Results for "Tailand Swine Influenza Vaccine Market"

01:20 EST 21st January 2017 | BioPortfolio

Matching Channels

Matching News

H1N1 'Swine Flu' Vaccine Unlikely to Raise Birth Defect Risk

MONDAY, Sept. 19, 2016 -- Swedish researchers report that the vaccine against the H1N1 "swine flu" strain of influenza doesn't seem to have a link to birth defects. One obstetrician who reviewed the r...

Influenza vaccine market to grow to £4.3 billion by 2025

GlobalData has released new findings which indicate that the seasonal influenza vaccine market is set to be worth $4.3 billion by 2025 across the seven major markets: US, UK, France, Italy, Germany, S...

FDA Approves Flublok Quadrivalent Influenza Vaccine

NewsProtein Sciences Corporation announced that the FDA has approved its influenza vaccine, which protects against four strains of influenza.

CDC Vaccine Information and Recommendations for the 2016/17 Influenza Season

With the start of a new school year and the approaching winter, it’s time to get informed about the most critical information regarding the 2016/17 influenza vaccines and CDC’s vaccination recomme...

Global Influenza Vaccine Market Outlook 2022 Prices from USD $2100

The global influenza vaccine industry has reported a significant growth in recent years, and is presenting ample opportunities to the industry's players. With increasing pandemic as well as seasonal o...

Swine flu vaccine is unlikely to raise risk of overall birth defects, study finds

Being given the H1N1 influenza vaccine during pregnancy does not seem to be associated with an increased risk of overall birth defects, a Swedish study published in Annals of Internal Medicine has... ...

Intranasal flu vaccine provides similar protection to injected flu vaccine, finds study

Intranasal live attenuated influenza vaccine achieves similar protection against infection with influenza in children, as well as similar herd immunity, as giving inactivated flu vaccine by...

Global Influenza Vaccine Market Outlook 2020 Prices from USD $2100

Influenza vaccines are considered as an optimum source of prevention from diseases caused by flu virus. Since the H1N1 pandemic, worldwide authorities have started to adopt proactive approach in the v...

Matching PubMed Articles

Influenza vaccine effectiveness: Maintained protection throughout the duration of influenza seasons 2010-2011 through 2013-2014.

Factors, such as age, comorbidities, vaccine type, herd immunity, previous influenza exposure, and antigenic shift, may impact the immune response to the influenza vaccine, protection against circulat...

Learning to Trust Flu Shots: Quasi-Experimental Evidence from the 2009 Swine Flu Pandemic.

This paper studies consumer learning in influenza vaccination decisions. We examine consumer learning in influenza vaccine demand within a reduced form instrumental variable framework that exploits di...

How to improve influenza vaccine coverage of healthcare personnel.

Influenza causes substantial morbidity and mortality worldwide each year. Healthcare-associated influenza is a frequent event. Health care personnel (HCP) may be the source for infecting patients and ...

Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials.

A quadrivalent influenza vaccine (QIV) includes two A strains (A/H1N1, A/H3N2) and two B lineages (B/Victoria, B/Yamagata). The presence of both B lineages eliminate potential B lineage mismatch of tr...

Influenza Vaccine Research funded by the European Commission FP7-Health-2013-Innovation-1 project.

Due to influenza viruses continuously displaying antigenic variation, current seasonal influenza vaccines must be updated annually to include the latest predicted strains. Despite all the efforts put ...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement